Octagon Capital Advisors LP
27 holdingsFiling period: 2026-06-30Current AUM: $917.3Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | 1.84M | $179.5M | $193.0M | 21.03% | -105,000 | 2026-06-30 |
| 2 | DFTX | DEFINIUM THERAPEUTICS INC | 2.95M | $138.8M | $108.6M | 11.84% | +510.0K | 2026-06-30 |
| 3 | ABVX | ABIVAX SA | 993.0K | $132.3M | $105.9M | 11.55% | +316.0K | 2026-06-30 |
| 4 | COGT | COGENT BIOSCIENCES INC | 2.35M | $90.9M | $76.9M | 8.39% | -- | 2026-06-30 |
| 5 | ALMS | ALUMIS INC | 2.83M | $79.7M | $23.8M | 2.59% | -- | 2026-06-30 |
| 6 | AVBP | ARRIVENT BIOPHARMA INC | 1.97M | $68.5M | $55.1M | 6.01% | -- | 2026-06-30 |
| 7 | TSHA | TAYSHA GENE THERAPIES INC | 9.69M | $66.0M | $49.0M | 5.35% | +833.3K | 2026-06-30 |
| 8 | BIOA | BIOAGE LABS INC | 1.75M | $42.8M | $14.3M | 1.56% | -- | 2026-06-30 |
| 9 | MIRM | MIRUM PHARMACEUTICALS INC | 338.9K | $39.7M | $31.8M | 3.47% | -- | 2026-06-30 |
| 10 | KYMR | KYMERA THERAPEUTICS INC | 310.0K | $35.5M | $35.1M | 3.82% | -115,000 | 2026-06-30 |
| 11 | AKTS | AKTIS ONCOLOGY INC | 960.8K | $31.0M | $21.5M | 2.35% | -- | 2026-06-30 |
| 12 | XENE | XENON PHARMACEUTICALS INC | 490.0K | $29.6M | $27.6M | 3.01% | -- | 2026-06-30 |
| 13 | ERAS | ERASCA INC | 1.25M | $23.0M | $20.4M | 2.22% | -- | 2026-06-30 |
| 14 | PALI | PALISADE BIO INC | 10.28M | $21.5M | $20.7M | 2.26% | -- | 2026-06-30 |
| 15 | OCUL | OCULAR THERAPEUTIX INC | 2.08M | $20.4M | $21.1M | 2.30% | -1,091,600 | 2026-06-30 |
| 16 | IRON | DISC MEDICINE INC | 270.0K | $19.7M | $18.2M | 1.98% | -- | 2026-06-30 |
| 17 | SMMT | SUMMIT THERAPEUTICS INC | 1.25M | $18.2M | $21.7M | 2.37% | -- | 2026-06-30 |
| 18 | — | PHARVARIS N V | 456.7K | $15.8M | $15.8M | 1.72% | +291.7K | 2026-06-30 |
| 19 | ANL | ADLAI NORTYE LTD | 934.7K | $10.7M | $14.0M | 1.53% | -- | 2026-06-30 |
| 20 | DTIL | PRECISION BIOSCIENCES INC | 1.35M | $10.6M | $8.9M | 0.97% | -886,732 | 2026-06-30 |
| 21 | DBVT | DBV TECHNOLOGIES S A | 574.2K | $9.4M | $6.8M | 0.74% | -- | 2026-06-30 |
| 22 | SNSE | FAETH THERAPEUTICS INC | 361.0K | $9.0M | $9.0M | 0.98% | -- | 2026-06-30 |
| 23 | GYRE | GYRE THERAPEUTICS INC | 954.4K | $6.3M | $6.4M | 0.70% | -- | 2026-06-30 |
| 24 | TRVI | TREVI THERAPEUTICS INC | 315.0K | $5.9M | $4.7M | 0.52% | -1,170,000 | 2026-06-30 |
| 25 | UNCY | UNICYCIVE THERAPEUTICS INC | 1.00M | $4.7M | $4.7M | 0.51% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2